EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

RETRACTION: Nrf3 Promotes 5‐FU Resistance in Colorectal Cancer Cells via the NF‐κB/BCL‐2 Signaling Pathway In Vitro and In Vivo

Journal Of Oncology

Journal of Oncology · 2026-01 · 2026 (1)

DOI: 10.1155/jo/9754059 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Oncology, online erschienen am 16.07.2026. Verfasst von Journal Of Oncology. Die Arbeit nennt 2 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

RETRACTION: B.-Q. Cai, W.-M. Chen, J. Zhao, W. Hou, and J. C. Tang, “Nrf3 Promotes 5-FU Resistance in Colorectal Cancer Cells via the NF-κB/BCL-2 Signaling Pathway In Vitro and In Vivo,” Journal of Oncology, 2021, 9355555, 12 pages, 2021, https://doi.org/10.1155/2021/9355555. The above article, published online on 09 November 2021 in Wiley Online Library (https://wileyonlinelibrary.com), has been retracted by John Wiley & Sons Ltd. In Figure 5f, the right-most three western blot bands in the Nrf3 group under the SW620/shNrf3 blots appear to have been mirrored 180 degrees from Figure 4c in [2]. In Figure 6d, the panel for Bcl-2 under the DMSO column in the HT29/Nrf3 group appears to have been duplicated from Figure 6c of [2], after being cropped and rotated 270 degrees. Due to these concerns, the publisher no longer has confidence in the validity of the conclusions. Therefore, the article is retracted.

Zitieren

APA

Oncology, J. O. (2026). RETRACTION: Nrf3 Promotes 5‐FU Resistance in Colorectal Cancer Cells via the NF‐κB/BCL‐2 Signaling Pathway In Vitro and In Vivo. Journal of Oncology, 2026(1). https://doi.org/10.1155/jo/9754059

Vancouver

Oncology JO. RETRACTION: Nrf3 Promotes 5‐FU Resistance in Colorectal Cancer Cells via the NF‐κB/BCL‐2 Signaling Pathway In Vitro and In Vivo. Journal of Oncology. 2026;2026(1). doi:10.1155/jo/9754059

BibTeX
@article{Oncology2026,
  author = {Oncology, Journal Of},
  title = {RETRACTION: Nrf3 Promotes 5‐FU Resistance in Colorectal Cancer Cells via the NF‐κB/BCL‐2 Signaling Pathway In Vitro and In Vivo},
  journal = {Journal of Oncology},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/jo/9754059}
}
Kostenlos starten →